Eirini Kanata
Overview
Explore the profile of Eirini Kanata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karagianni K, Dafou D, Xanthopoulos K, Sklaviadis T, Kanata E
Mol Med
. 2024 Jul;
30(1):101.
PMID: 38997636
Background: Amyotrophic Lateral Sclerosis (ALS) is a highly heterogenous neurodegenerative disorder that primarily affects upper and lower motor neurons, affecting additional cell types and brain regions. Underlying molecular mechanisms are...
2.
Chatziefstathiou A, Canaslan S, Kanata E, Vekrellis K, Constantinides V, Paraskevas G, et al.
Biomedicines
. 2024 Jun;
12(6).
PMID: 38927460
Background: Accurate diagnosis of Alzheimer's disease (AD) and frontotemporal dementia (FTD) represents a health issue due to the absence of disease traits. We assessed the performance of a SIMOA panel...
3.
Paspaltsis I, Kanata E, Sotiriadis S, Correia S, Schmitz M, Zerr I, et al.
Pathogens
. 2024 May;
13(5).
PMID: 38787272
Prions are proteinaceous pathogens responsible for a variety of devastating diseases in mammals, including scrapie in sheep and goats, chronic wasting disease in cervids, and Creutzfeldt-Jakob disease (CJD) in humans....
4.
Christoudia N, Bekas N, Kanata E, Chatziefsthathiou A, Pettas S, Karagianni K, et al.
Redox Biol
. 2024 Apr;
72:103133.
PMID: 38565068
Prion diseases, also known as Transmissible Spongiform Encephalopathies (TSEs), are protein-based neurodegenerative disorders (NDs) affecting humans and animals. They are characterized by the conformational conversion of the normal cellular prion...
5.
Kanata E, Paspaltsis I, Sotiriadis S, Berberidou C, Tsoumachidou S, Dafou D, et al.
Molecules
. 2023 Feb;
28(3).
PMID: 36770868
Photocatalytic inactivation of pathogens in aqueous waste is gaining increasing attention. Several homogeneous and heterogeneous photocatalytic protocols exist using the Fenton's reagent and TiO, respectively. A comprehensive study of homogeneous...
6.
Founta K, Dafou D, Kanata E, Sklaviadis T, Zanos T, Gounaris A, et al.
Mol Med
. 2023 Jan;
29(1):12.
PMID: 36694130
Background: Amyotrophic lateral sclerosis (ALS) is a rare progressive neurodegenerative disease that affects upper and lower motor neurons. As the molecular basis of the disease is still elusive, the development...
7.
Dafou D, Kanata E, Pettas S, Bekas N, Dimitriadis A, Kempapidou G, et al.
Cells
. 2022 Nov;
11(22).
PMID: 36429012
RNA editing is an epitranscriptomic modification, leading to targeted changes in RNA transcripts. It is mediated by the action of ADAR (adenosine deaminases acting on double-stranded (ds) RNA and APOBEC...
8.
Pettas S, Karagianni K, Kanata E, Chatziefstathiou A, Christoudia N, Xanthopoulos K, et al.
Cells
. 2022 Aug;
11(15).
PMID: 35954228
Microglia are macrophages present in the brain that function as the primary and most important source of immune response in the central nervous system (CNS). Regardless of their multitasking role,...
9.
Karagianni K, Pettas S, Kanata E, Lioulia E, Thune K, Schmitz M, et al.
Antioxidants (Basel)
. 2022 Apr;
11(4).
PMID: 35453411
Prion diseases are transmissible encephalopathies associated with the conversion of the physiological form of the prion protein (PrP) to the disease-associated (PrP). Despite intense research, no therapeutic or prophylactic agent...
10.
Karagianni K, Pettas S, Christoforidou G, Kanata E, Bekas N, Xanthopoulos K, et al.
Biomolecules
. 2022 Mar;
12(3).
PMID: 35327657
RNA editing contributes to transcriptome diversification through RNA modifications in relation to genome-encoded information (RNA-DNA differences, RDDs). The deamination of Adenosine (A) to Inosine (I) or Cytidine (C) to Uridine...